semaglutide shortage end FDA Ends Listing, Contributing to Ongoing Legal Challenges Semaglutide shortage ends as FDA

Taken together, the clinical impact of GLP-1RA over 2 decades has been substantial and seems likely to be expanded, based on forthcoming clinical trial data and investigational drug development activity, in the years to come

Related Reading Berberine Benefits Berberine Dosage Magnesium Glycinate Benefits Ashwagandha Benefits Magnesium Deficiency Symptoms Creatine For Older Adults Nmn Benefits Supplement Stacks Guide Berberine For Weight Loss Magnesium Glycinate Side Effects Ashwagandha Side Effects Related reading What is GLP-1

Phase 3 trials typically take several years to complete, and results from the TRIUMPH programme are anticipated broadly in the 20252027 timeframe based on estimated completion dates registered on ClinicalTrials.gov, though this is subject to change

Under standard review timelines, that places potential FDA approval somewhere around mid to late next year